Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Audentes Therapeutics amends IPO

    Audentes Therapeutics Inc., San Francisco, Calif. Business: Gene/Cell therapy, Cardiovascular, Endocrine/Metabolic Date announced: 2016-07-11 Type: IPO To be raised: Up to $80 million Shares: 5 million Price: $14-$16 …

    Published on 7/18/2016
  • ImmunoCellular amends follow-on

    ImmunoCellular Therapeutics Ltd. (NYSE-M:IMUC), Calabasas, Calif. Business: Cancer Date announced: 2016-07-11 Type: Follow-on To be raised: Up to $24.2 million Shares: 60 million Price Prior: $0.27 Underwriters: Maxim …

    Published on 7/18/2016
  • Kadmon amends IPO

    Kadmon Holdings LLC, New York, N.Y. Business: Cancer, Autoimmune, Infectious Date announced: 2016-07-14 Type: IPO To be raised: Up to $111.1 million Shares: 5.6 million Price: $16-$20 Underwriters: Citigroup; Jefferies;…

    Published on 7/18/2016
  • Patheon amends IPO

    Patheon N.V., Amsterdam, the Netherlands Business: Supply/Service Date announced: 2016-07-11 Type: IPO To be raised: Up to $563.4 million Shares: 25.6 million Price: $19-$22 Underwriters: JPMorgan; Morgan Stanley; …

    Published on 7/18/2016
  • Xenetic amends follow-on

    Xenetic Biosciences Inc. (OTCQB:XBIO), Lexington, Mass. Business: Drug delivery, Cancer, Hematology Date announced: 2016-07-08 Type: Follow-on To be raised: Up to $15 million Units: 3 million Price Prior: $0.24 …

    Published on 7/18/2016
  • 3Scan completes venture financing

    3Scan, San Francisco, Calif. Business: Supply/Service Date completed: 2016-07-11 Type: Venture financing Raised: $14 million Investors: Lux Capital; Data Collective; Dolby Family Ventures; OS Fund; Comet Labs; Breakout …

    Published on 7/18/2016
  • Acticor Biotech completes venture financing

    Acticor Biotech, Paris, France Business: Antibodies, Neurology Date completed: 2016-07-11 Type: Venture financing Raised: EUR670,000 ($738,742) Investors: ARMESA; angel investors Note: Acticor also raised an additional …

    Published on 7/18/2016
  • Adamis completes private placement of units

    Adamis Pharmaceuticals Corp. (NASDAQ:ADMP), San Diego, Calif. Business: Inflammation, Cancer, Endocrine/Metabolic Date completed: 2016-07-12 Type: Private placement of units Raised: $5 million Units: 1.7 million Price:…

    Published on 7/18/2016
  • Avita completes rights offering

    Avita Medical Ltd. (ASX:AVH; OTCQX:AVMXY), Perth, Australia Business: Gene/Cell therapy, Dermatology Date completed: 2016-07-04 Type: Rights offering Raised: A$9 million ($6.8 million) Shares: 100.2 million Price: A$0.…

    Published on 7/18/2016
  • Ceapro completes private placement of units

    Ceapro Inc. (TSX-V:CZO), Edmonton, Alberta Business: Dermatology, Nutraceuticals, Veterinary Date completed: 2016-07-14 Type: Private placement of units Raised: C$10 million ($7.6 million) Units: 9.4 million Price: C$1.…

    Published on 7/18/2016
  • CytRx completes direct public offering

    CytRx Corp. (NASDAQ:CYTR), Los Angeles, Calif. Business: Cancer, Musculoskeletal Date completed: 2016-07-15 Type: Direct public offering Raised: $20 million Shares: 28.6 million Price: $0.70 Shares after offering: 95.4 …

    Published on 7/18/2016
  • Epistem completes placing

    Epistem Holdings plc (LSE:EHP), Manchester, U.K. Business: Diagnostic, Supply/Service, Gene/Cell therapy Date completed: 2016-07-11 Type: Placing Raised: L6.5 million ($8.4 million) Shares: 8.1 million Price: 80p Shares…

    Published on 7/18/2016
  • Galena Biopharma completes direct public offering

    Galena Biopharma Inc. (NASDAQ:GALE), Portland, Ore. Business: Cancer, Hematology, Gastrointestinal Date completed: 2016-07-13 Type: Direct public offering Raised: $12.6 million Shares: 28 million Price: $0.45 Shares …

    Published on 7/18/2016
  • GenSight Biologics completes IPO

    GenSight Biologics S.A. (Euronext:SIGHT), Paris, France Business: Ophthalmic Date completed: 2016-07-12 Type: IPO Raised: EUR40 million ($44.1 million) Shares: 5 million Price: EUR8 Shares after offering: 18.6 million …

    Published on 7/18/2016
  • GW Pharma completes follow-on

    GW Pharmaceuticals plc (LSE:GWP; NASDAQ:GWPH), Salisbury, U.K. Business: Neurology, Endocrine/Metabolic, Cancer Date completed: 2016-07-12 Type: Follow-on Raised: $252 million Shares: 2.8 million Price: $90 Shares after…

    Published on 7/18/2016
  • Pharnext completes IPO

    Pharnext S.A.S. (Euronext:ALPHA), Issy-Les-Moulineaux, France Business: Neurology Date completed: 2016-07-13 Type: IPO Raised: EUR30.9 million ($34.1 million) Shares: 2.9 million Price: EUR10.82 Shares after offering: …

    Published on 7/18/2016
  • Sapience completes venture financing

    Sapience Therapeutics Inc., Scarsdale, N.Y. Business: Cancer Date completed: 2016-07-12 Type: Venture financing Raised: $22.5 million Investors: Eshelman Ventures; Celgene Corp.; TaiAn Technologies; Healthlink Capital

    Published on 7/18/2016
  • BliNK Biomedical financial update

    BliNK Biomedical S.A.S., Lyon, France Business: Cancer, Antibodies Date announced: 2016-07-12 Note: BliNK Biomedical raised EUR1.7 million ($1.8 million) in an additional close of a series A round, bringing the total …

    Published on 7/18/2016
  • Hanmi Pharmaceutical financial update

    Hanmi Pharmaceutical Co. Ltd. (KOSDAQ:128940), Seoul, South Korea Business: Pharmaceuticals, Cancer, Cardiovascular Date announced: 2016-07-14 Note: Hanmi Pharmaceutical established Hanmi Ventures with W10 billion ($9 …

    Published on 7/18/2016
  • Longwood Fund financial update

    Longwood Fund, Boston, Mass. Business: Finance Date announced: 2016-07-11 Note: Healthcare VC Longwood Fund plans to raise $90 million for Longwood Fund IV L.P., according to an SEC filing.

    Published on 7/18/2016
  • Polaris Partners financial update

    Polaris Partners, Boston, Mass. Business: Finance Date announced: 2016-07-12 Note: Polaris Partners plans to raise $400 million for Polaris Partners VIII L.P., according to an SEC filing. Polaris closed its seventh fund…

    Published on 7/18/2016
  • Sienna Biopharmaceuticals financial update

    Sienna Biopharmaceuticals Inc., Westlake Village, Calif. Business: Dermatology Date announced: 2016-07-12 Note: Sienna Biopharmaceuticals raised $12 million in a second close of a series A round, bringing the total …

    Published on 7/18/2016
  • Tonix financial update

    Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), New York, N.Y. Business: Neurology, Musculoskeletal Date announced: 2016-07-12 Note: Tonix raised $1.5 million through the sale of 750,000 shares at $2 to cover the …

    Published on 7/18/2016
  • Valneva financial update

    Valneva SE (Euronext:VLA; VSE:VLA), Lyon, France Business: Antibodies, Infectious, Gastrointestinal Date announced: 2016-07-12 Note: Valneva secured a five-year, EUR25 million ($27.6 million) loan facility from the …

    Published on 7/18/2016
  • Vigilant Biosciences financial update

    Vigilant Biosciences Inc., Miami, Fla. Business: Diagnostic Date announced: 2016-07-11 Note: Vigilant raised $5 million in an extension of a series B round, bringing the total raised in the round to $10.5 million. White…

    Published on 7/18/2016

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993